World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
21265
World Ranking
15287
National Ranking
35

Peter R. Donald publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter R. Donald sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 314 publications — 20th percentile

20% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter R. Donald D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter R. Donald sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 84 D-Index — 27th percentile

27% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter R. Donald is affiliated with Stellenbosch University in South Africa and conducts research primarily in the field of Medicine. Their work focuses on several subfields including Infectious Diseases, Pharmacology, Immunology, Surgery, and Pediatrics, Perinatology, and Child Health.

The scientist's research interests encompass a range of topics such as Tuberculosis Research and Epidemiology, Immunodeficiency and Autoimmune Disorders, Antibiotics Pharmacokinetics and Efficacy, Infectious Diseases and Tuberculosis, Drug Transport and Resistance Mechanisms, Pharmacological Effects of Natural Compounds, and Immune Responses and Vaccinations.

Among their published papers are:

  • Anton Ghon and His Colleagues and Their Studies of the Primary Focus and Complex of Tuberculosis Infection and Their Relevance for the Twenty-First Century, 2020, Respiration
  • 100 years of Mycobacterium bovis bacille Calmette-Guérin, 2021, The Lancet Infectious Diseases
  • The pharmacokinetics of para-aminosalicylic acid and its relationship to efficacy and intolerance, 2020, British Journal of Clinical Pharmacology
  • Global estimates and determinants of antituberculosis drug pharmacokinetics in children and adolescents: a systematic review and individual patient data meta-analysis, 2022, European Respiratory Journal
  • Tuberculous Meningitis in Children: A Forgotten Public Health Emergency, 2022, Frontiers in Neurology

Frequent coauthors in their research include H. Simon Schaaf, Anneke C. Hesseling, Stephanie Thee, Helen McIlleron, and Paolo Denti.

The scientist's studies have been published predominantly in venues such as Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases, European Respiratory Journal, Frontiers in Neurology, and British Journal of Clinical Pharmacology.

Best Publications

  • Tuberculous meningitis: a uniform case definition for use in clinical research

    Suzaan Marais;Guy Thwaites;Johan F Schoeman;M Estée Török

  • The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era.

    B J Marais;R P Gie;H S Schaaf;A C Hesseling

  • Childhood pulmonary tuberculosis: old wisdom and new challenges.

    Ben J. Marais;Robert P. Gie;H. Simon Schaaf;Nulda Beyers

  • 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial

    Andreas H Diacon;Rodney Dawson;Florian von Groote-Bidlingmaier;Gregory Symons

  • Randomized Pilot Trial of Eight Weeks of Bedaquiline (TMC207) Treatment for Multidrug-Resistant Tuberculosis: Long-Term Outcome, Tolerability, and Effect on Emergence of Drug Resistance

    A. H. Diacon;P. R. Donald;A. Pym;M. Grobusch

  • Effect of corticosteroids on intracranial pressure, computed tomographic findings, and clinical outcome in young children with tuberculous meningitis.

    J F Schoeman;L E Van Zyl;J A Laubscher;P R Donald

  • Early Bactericidal Activity and Pharmacokinetics of the Diarylquinoline TMC207 in Treatment of Pulmonary Tuberculosis

    R. Rustomjee;A. H. Diacon;J. Allen;A. Venter

  • Twenty Years of Pediatric Tuberculous Meningitis: A Retrospective Cohort Study in the Western Cape of South Africa

    G. T. J. van Well;B. F. Paes;C. B. Terwee;P. Springer

  • Why Do We Use 600 mg of Rifampicin in Tuberculosis Treatment

    Jakko van Ingen;Rob E. Aarnoutse;Peter R. Donald;Andreas H. Diacon

  • Efficiency and safety of the combination of moxifloxacin, pretomanid (PA-824), and pyrazinamide during the first 8 weeks of antituberculosis treatment: a phase 2b, open-label, partly randomised trial in patients with drug-susceptible or drug-resistant pulmonary tuberculosis

    Rodney Dawson;Andreas H Diacon;Daniel Everitt;Christo van Niekerk

  • The clinical epidemiology of childhood pulmonary tuberculosis: A critical review of literature from the pre-chemotherapy era

    B J Marais;R P Gie;H S Schaaf;A C Hesseling

  • Evaluation of Young Children in Contact With Adult Multidrug-Resistant Pulmonary Tuberculosis: A 30-Month Follow-up

    H. Simon Schaaf;Robert P. Gie;Magdalene Kennedy;Nulda Beyers

  • Trimodality of isoniazid elimination: phenotype and genotype in patients with tuberculosis.

    D. P. Parkin;S. Vandenplas;F. J. H. Botha;M. L. Vandenplas

  • Early bactericidal activity of delamanid (OPC-67683) in smear-positive pulmonary tuberculosis patients.

    A H Diacon;R Dawson;M Hanekom;K Narunsky

  • Cerebrospinal fluid concentrations of antituberculosis agents in adults and children

    P.R. Donald

  • Mortality in children diagnosed with tuberculosis: a systematic review and meta-analysis

    Helen E Jenkins;Helen E Jenkins;Courtney M Yuen;Courtney M Yuen;Carly A Rodriguez;Ruvandhi R Nathavitharana

  • A PROPOSED RADIOLOGICAL CLASSIFICATION OF CHILDHOOD INTRA-THORACIC TUBERCULOSIS

    Ben J. Marais;Robert P. Gie;H. Simon Schaaf;Jeff R. Starke

  • Early Bactericidal Activity of High-Dose Rifampin in Patients with Pulmonary Tuberculosis Evidenced by Positive Sputum Smears

    A. H. Diacon;R. F. Patientia;A. Venter;P. D. van Helden

  • Early Bactericidal Activity and Pharmacokinetics of PA-824 in Smear-Positive Tuberculosis Patients

    Andreas H. Diacon;Rodney Dawson;Madeleine Hanekom;Kim Narunsky

  • Respiratory tuberculosis in childhood: the diagnostic value of clinical features and special investigations.

    Hendrik S. Schaaf;Nulda Beyers;Robert P. Gie;Etienne D. Nel

Frequent Co-Authors

Nulda Beyers
Nulda Beyers Stellenbosch University
Ben J. Marais
Ben J. Marais University of Sydney
Robin M. Warren
Robin M. Warren Stellenbosch University
Thomas C. Victor
Thomas C. Victor Stellenbosch University
Paul D. van Helden
Paul D. van Helden Stellenbosch University
Peter Smith
Peter Smith University of Aberdeen
Stephen M. Graham
Stephen M. Graham University of Melbourne
Jan L. L. Kimpen
Jan L. L. Kimpen Boston Children's Hospital
Stephen H. Gillespie
Stephen H. Gillespie University of St Andrews
Rifat Atun
Rifat Atun Harvard University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Interested in healthcare but seeking alternative or supplementary pathways to a traditional MD? Online degrees open new doors for both aspiring students and practicing professionals in the medical field. These flexible programs allow you to advance your career or specialize without relocating or pausing work.

For nurses aiming for leadership roles, check out the cheapest online bsn to dnp programs. Pharmacists can expand their qualifications and earning potential through cheapest online pharmacy school options that are cost-effective and accredited.

Healthcare data is a booming sector. Pursuing a degree in health informatics equips you for in-demand roles focused on the ethical management of health information and technology.

Looking for a quick entry into the medical administrative field? Medical coding certification online can help you launch a career in medical billing, coding, and data management—often in a year or less!

Best Scientists Citing Peter R. Donald

Trending Scientists

Recently Published Articles